Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05981833

Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears

The purpose of this study is to compare postoperative healing of large and massive rotator cuff tears with preoperative MRI confirmed fatty infiltration stage II and higher repaired with or without dermal allograft augmentation (DAA).

Recruiting

Interested in participating?

Request Info

Key information

Age range

30 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Arizona, Banner Health, Scottsdale, Arizona, United States

Loading trial locations.

About this study

The primary objective is to evaluate postoperative healing of rotator cuff repair with and without DAA.

Primary: The primary outcome measure is healing evaluation in MRI . MRI Post-Operative Assessment (Goutallier Stage and Sugaya Classification)

Secondary: The secondary outcome measures are patient-reported outcome measures from validated outcome scoring systems, including:

American Shoulder and Elbow Surgeons Score (ASES)

Single Assessment Numeric Evaluation score (SANE)

Visual Analog Scale (VAS) for pain

Veterans RAND Health Survey (VR-12)

Population: Males and females between the ages of 30 and 75 years that require surgery for large and massive rotator cuff tears

Description of Treatment: Rotator cuff repair with or without augmentation using decellularized human dermal allograft.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The subject is between the ages of 30 and 75 years.
  • Subject is planning to undergo arthroscopic surgery for full-thickness rotator cuff tear (RCT)
  • Two complete RCTs or tear size equal to or greater than 3 cm in either the anterior-posterior or medial-lateral dimension
  • Primary rotator cuff repair
  • Stage II fatty infiltration or higher of the supraspinatus or infraspinatus muscle based on preoperative MRI6. Subject has a dual x-ray absorptiometry (DXA) or anterior posterior x-ray view of the target shoulder

Exclusion criteria

  • The Subject is unable or unwilling to sign the patient informed consent, approved by the Institutional Review Board.
  • The subject objects to the use of allograft
  • Stage I or lower fatty infiltration of the supraspinatus AND infraspinatus muscle
  • Complete full-thickness subscapularis tears of greater than the superior one third of the tendon (Lafosse grade 3 and above)
  • Less than 2 mm joint space of the glenohumeral joint on either an anteroposterior or axillary radiograph
  • Recurrent shoulder instability
  • Corticosteroid injection in the operative shoulder within one month of surgery
  • Revision rotator cuff repair
  • Subject preoperative MRI obtained more than 12 months prior to surgery
  • Pregnant or planning to become pregnant during the study period
  • Workman's compensation case
  • Subject has conditions or circumstances that would interfere with study requirements.

Intraoperative exclusion criteria:

Partial rotator cuff repairs

Lafosse grade 3 or higher subscapularis tears

Treatment and study plan

Repair with DAA (dermal allograft augmentation)

Device

Patients undergo rotator cuff repair with dermal allograft augmentation.

Primary outcomes

  1. The primary outcome measure is healing evaluation in MRI

    Time frame: 26 Weeks

    MRI Post-Operative Assessment (Goutallier Stage and Sugaya Classification)

    MRI Post-Operative Assessment (Goutallier Stage and Sugaya Classification)

Secondary outcomes

  1. The secondary outcome measures are patient-reported outcome measures from validated outcome scoring systems

    Time frame: Preop, 26 Weeks, 1 Year, 2 Year

    • American Shoulder and Elbow Surgeons Score (ASES) A combination of objective measures and patient-reported outcomes, it measures pain and functional limitations in the shoulder. The objective questionnaire allows documentation of range of motion in the patient.
  2. Single Assessment Numeric Evaluation score (SANE)

    Time frame: Preop, 26 Weeks, 1 Year, 2 Year

    Asks patients to rate shoulder pain as a percentage of normal.

  3. Visual Analog Scale (VAS) for pain

    Time frame: Preop, two-week, six week, 26 Weeks, 1 Year, 2 Year

    The standard measure for pain on a 0-10 scale, 10 being the worst.

  4. Veterans RAND Health Survey (VR-12)

    Time frame: Preop, 26 Weeks, 1 Year, 2 Year

    A self-administered health measure. Answers are summarized into two scores, a Physical Component Score and a Mental Component Score, which provides an important contrast between the respondents' physical and psychological health status.

Study contacts

Contact information is provided by the study sponsor or research team.

Caroline Caraci, BA

CONTACT

[email protected]

18009337001

Sponsors and collaborators

Lead sponsor

Arthrex, Inc.

Industry

Registry information

Official study title

A Randomized, Post-market Study Evaluating Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears

Important dates

Study start
2023
Primary completion
2025
Study completion
2026
First posted
Aug 8, 2023
Registry last updated
Feb 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.